Safety and Effectiveness of CPI-1189 in HIV-Infected Males on Combination Anti-HIV Drug Therapy

NCT00002209 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

AIDS Dementia Complex
HIV Infections

Interventions

DRUG: CPI-1189

Sponsor

Centaur Pharmaceuticals